Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP792438.RAZzpsY6Jb7f6nj5NNvGh0Zpw5xE-L-MEFyH_LZNFz8O0130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP792438.RAZzpsY6Jb7f6nj5NNvGh0Zpw5xE-L-MEFyH_LZNFz8O0130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP792438.RAZzpsY6Jb7f6nj5NNvGh0Zpw5xE-L-MEFyH_LZNFz8O0130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP792438.RAZzpsY6Jb7f6nj5NNvGh0Zpw5xE-L-MEFyH_LZNFz8O0130_provenance.
- NP792438.RAZzpsY6Jb7f6nj5NNvGh0Zpw5xE-L-MEFyH_LZNFz8O0130_assertion description "[This phenomenon could be ligand independent, as the AhR ligand 2,3,7,8-Tetrachlorodibenzo-p-Dioxin (TCDD) did not alter prostate cancer cell growth.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP792438.RAZzpsY6Jb7f6nj5NNvGh0Zpw5xE-L-MEFyH_LZNFz8O0130_provenance.
- NP792438.RAZzpsY6Jb7f6nj5NNvGh0Zpw5xE-L-MEFyH_LZNFz8O0130_assertion evidence source_evidence_literature NP792438.RAZzpsY6Jb7f6nj5NNvGh0Zpw5xE-L-MEFyH_LZNFz8O0130_provenance.
- NP792438.RAZzpsY6Jb7f6nj5NNvGh0Zpw5xE-L-MEFyH_LZNFz8O0130_assertion SIO_000772 20140206 NP792438.RAZzpsY6Jb7f6nj5NNvGh0Zpw5xE-L-MEFyH_LZNFz8O0130_provenance.
- NP792438.RAZzpsY6Jb7f6nj5NNvGh0Zpw5xE-L-MEFyH_LZNFz8O0130_assertion wasDerivedFrom befree-2016 NP792438.RAZzpsY6Jb7f6nj5NNvGh0Zpw5xE-L-MEFyH_LZNFz8O0130_provenance.
- NP792438.RAZzpsY6Jb7f6nj5NNvGh0Zpw5xE-L-MEFyH_LZNFz8O0130_assertion wasGeneratedBy ECO_0000203 NP792438.RAZzpsY6Jb7f6nj5NNvGh0Zpw5xE-L-MEFyH_LZNFz8O0130_provenance.
- befree-2016 importedOn "2016-02-19" NP792438.RAZzpsY6Jb7f6nj5NNvGh0Zpw5xE-L-MEFyH_LZNFz8O0130_provenance.